Abstract
Pulmonary hypertension (PH) denotes a poor prognosis in patients with left-sided heart disease. No study has demonstrated long-term benefit from PH drugs such as prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors. In some cases, cautious use of PH drugs may be indicated. However, theoretic and practical concerns limit any formal recommendations.
MeSH terms
-
Antihypertensive Agents / therapeutic use
-
Comorbidity
-
Exercise Test
-
Heart Diseases / epidemiology*
-
Heart Diseases / surgery
-
Heart Transplantation
-
Humans
-
Hypertension, Pulmonary / classification
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / epidemiology*
-
Hypertension, Pulmonary / physiopathology
-
Prognosis
-
Ventricular Function, Left